Evidence map›Paper›PMID 41683825›Full record

ArticleInternational journal of molecular sciences2026

Peihua Wen, Xinru Jian, Xiaoyu Ren, Shusen Zhao, Yuhan Yang, Haotian Ge, Longjie Li, Hongxun Wang, Maoteng Li, Limei Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Peihua WenSchool of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430048, China.
Xinru JianSchool of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430048, China.
Xiaoyu RenSchool of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430048, China.
Shusen ZhaoSchool of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430048, China.ORCID 0009-0009-2810-6759
Yuhan YangSchool of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430048, China.
Haotian GeSchool of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430048, China.
Longjie LiSchool of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430048, China.
Hongxun WangSchool of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430048, China.
Maoteng LiXianghu Laboratory, Biological Seed Industry Research Institute, Hangzhou 311231, China.ORCID 0000-0003-1655-9637
Limei WangSchool of Life Science and Technology, Wuhan Polytechnic University, Wuhan 430048, China.

Funding

Hubei Provincial Natural Science Foundation (2022CFB429)Wuhan East Lake New Technology Development Zone "unveiled the list of marshal" 2024KJB351
6 · The paper itself

Abstract

Acute liver failure (ALF) is a rapidly progressive and life-threatening condition with limited pharmacological interventions.

Indexed as

GalactosamineLipopolysaccharidesLiver Failure, AcuteWolfiporiaAnimalsApoptosisLiverMaleMolecular Docking SimulationNetwork PharmacologyPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleySignal TransductionGalactosamineLipopolysaccharidesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktacute liver failureinflammationnetwork pharmacologyPI3K/AKT pathwayPoria cocos

Identifiers

PMID41683825
PMCPMC12897855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.